cbdMD, Inc. ( YCBD) - Key Metrics
YCBD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.52 | -$0.11 | -$41.65 | -$43.35 |
| 2026Q2 | $0.54 | -$0.08 | -$0.07 | -$0.07 |
| 2026Q1 | $0.56 | -$0.03 | -$0.09 | -$18.30 |
| 2025Q4 | $0.53 | -$0.08 | -$0.03 | -$0.03 |
| 2025Q3 | $0.80 | -$0.15 | -$0.12 | -$0.12 |
YCBD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | -10670.31% | -1.53 |
| 2026Q2 | 0% | -2.21 |
| 2026Q1 | 0% | -9.35 |
| 2025Q4 | 0% | -3.96 |
| 2025Q3 | 0% | -1.06 |
YCBD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | -6441.20% | 1683.36% |
| 2026Q2 | -9.40% | 0% |
| 2026Q1 | -1355.80% | 0% |
| 2025Q4 | -2.26% | 0% |
| 2025Q3 | -13.68% | 0% |
YCBD
Price: $0.34
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.23 USD
P/E Ratio: 2.04
Exchange: ASE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 457300
Market Capitalization: 4.3 million